Microbiome Therapeutics Market By Product Type (Probiotics, Prebiotics, Synbiotics, Live Biotherapeutic Products, Fecal Microbiota Transplantation), By Route Of Administration (Oral, Rectal, Others), By Application (Gastrointestinal Disorders, Metabolic Disorders, Infectious Diseases, Neurological Disorders, Cancer, Others), And By End-User (Hospitals & Clinics, Research & Academic Institutes, Pharmaceutical & Biotechnology Companies), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Product Type

• Probiotics
• Prebiotics
• Synbiotics
• Live Biotherapeutic Products
• Fecal Microbiota Transplantation

By Route of Administration

• Oral
• Rectal
• Others

By Application

• Gastrointestinal Disorders
• Metabolic Disorders
• Infectious Diseases
• Neurological Disorders
• Cancer
• Others

By End-User

• Hospitals & Clinics
• Research & Academic Institutes
• Pharmaceutical & Biotechnology Companies

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Seres Therapeutics
• Vedanta Biosciences
• Rebiotix (a Ferring Company)
• Finch Therapeutics
• Second Genome
• 4D Pharma
• Enterome
• Symbiotix Biotherapies
• Axial Therapeutics
• Microbiotica
• Evelo Biosciences
• Quorum Innovations
• LiveBiome
• BiomX
• Osel Inc.